Stevens-Johnson Syndrome Causes & Symptoms
Drug Injury Lawyers
What should I do if I have these symptoms?
If you are experiencing symptoms of Stevens-Johnson Syndrome (SJS), the Houston drug injury lawyers from Terry Bryant Accident & Injury Law may be able to help you. Terry Bryant is board certified and has the experience to win your case. Call our Houston drug injury attorneys today at (800) 444-5000 or complete a free initial consultation form.
What causes SJS?
SJS has been documented as a side effect of or reaction to several situations, including:
- antibiotics
- anti-convulsants (such as Dilantin®)
- barbiturates
- malignant diseases
- nonsteroidal anti-inflammatory drugs (NSAIDs), both prescription and over-the-counter
- sulfa or sulfa-containing drugs
- viral or bacterial infections
Between 25 and 50 percent of all cases of SJS are reportedly idiopathic, which are cases that arise spontaneously with no apparent origin or cause.
What are the symptoms of SJS?
The symptoms of SJS often progress in severity as follows, especially if left untreated:
- blisters or lesions on the mucous membranes (thin moist tissues that line body cavities) of the mouth, nose, eyes, genitals, urinary tract, GI tract, or respiratory tract
- blisters or rashes on the skin
- flu-like symptoms, including fever, fatigue, headache, sore throat, cough, nausea, etc.
- ulceration of blisters leading to shedding of the skin
Anyone is at risk for SJS, especially people exposed to known SJS causes such as taking certain medications. These people should seek immediate medical attention at the first appearance of rash, blisters on the mucous membranes, or signs of hypersensitivity, including allergic reactions that involve breathing problems.
Early diagnosis by a medical professional could result in a better chance of focused, effective treatment.
More About SJS » SJS Treatment »
Dilantin® is a registered trademark of Pfizer, Inc.
This law firm is not affiliated with, sponsored by, or associated with the Stevens-Johnson Syndrome Foundation or Pfizer, Inc.
